JP Patent

JP7499249B2 — 副甲状腺ホルモン（ｐｔｈ）および副甲状腺ホルモン関連ペプチド（ｐｔｈｒｐ）アナログに対する中和抗体を検出するための方法

Assigned to ラジウス ヘルス，インコーポレイテッド · Expires 2024-06-13 · 2y expired

What this patent protects

Patent listed against Tymlos.

Drugs covered by this patent

Patent Metadata

Patent number
JP7499249B2
Jurisdiction
JP
Classification
—
Expires
2024-06-13
Drug substance claim
No
Drug product claim
No
Assignee
ラジウス ヘルス，インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.